EUDA Health Holdings Limited (EUDAW) Stock Price & Analysis
EUDA Health Holdings Limited (EUDAW) — price $0.0224 (-17.95%), as of the Oct 5, 2026 trading session.
Educational signal · not a buy or sell recommendation · How to read this
EUDA Health Holdings Limited · EUDAW
As a subsidiary of Watermark Developments Limited, the company functions within the healthcare technology sector, addressing the growing demand for accessible digital health services.
Price as of Oct 5, 2026
Key Statistics
Not scored: this is a debt/preferred or other non-common instrument, or its reported market value does not match its share basis.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $0.0224 | |
| Change on the day | -17.95% | |
| 52-week range | $0.0101 – $0.30 | |
| Shares traded on the day | 9.9K |
Price & events
Other perspectives
Council score for EUDA Health Holdings (EUDAW): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
9-Factor Breakdown
Legends Council
4 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 6, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Apr 30, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Apr 30, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Oct 6, 2026, except a card that shows its own read date.
Watch the EUDAW film — every key number, told as a short cinematic story
~2 min · open the film
What is EUDA Health Holdings (EUDAW), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. EUDA Health Holdings Limited (EUDAW) is the company analyzed here. It employs 123 people and is led by Alfred Lim. In Q4 FY2025 it reported revenue of $7M and net income of -$3M.
What do the latest results show for EUDA Health Holdings (EUDAW)?
Short answer · as of
The most recent reported quarter, Q4 FY2025, carried revenue of $7M.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q4 FY2025 | $7M | -$3M | -$1.49 (diluted) |
| Q3 FY2025 | $2M | -$784,380 | -$0.42 (diluted) |
| Q2 FY2025 | $2M | -$602,000 | -$0.32 (diluted) |
| Q1 FY2025 | $2M | -$602,000 | -$0.32 (diluted) |
What are the financial strengths and risks for EUDA Health Holdings (EUDAW)?
Short answer · as of
The distress and quality screens read Piotroski F 2. Trailing ratios: ROE 102.1% · current ratio 0.18 · earnings yield -13.0% · free-cash-flow yield -11.7%.
What should you watch next at EUDA Health Holdings (EUDAW)?
Short answer · as of
Analyst estimates on file carry FY2026 revenue $27.23M · EPS 0.00 · 1 analysts.
What the records here don't tell us
- The next earnings date is not yet scheduled in the calendar we read.
Checked against the records this page reads, on the dates shown above.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Revenue estimate
- $27.23M
- EPS estimate
- $0.00
Measured against a quoted price of $0.0224 (as of Oct 5, 2026).
Insider activity
Form 4 records via FMP · Most recent available transactions
- Transactions
- 7
- Identified insiders
- 2
- Purchases
- 3
- Sales
- 0
- Other transactions
- 4
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
What has been published about EUDA Health Holdings (EUDAW)?
Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources — records for every figure on this page (16 figures)
The 16 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.
"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.
FMP — 8 facts from Financial Modeling Prep endpoint families
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.last | Latest provided price | $0.0224 | FMP | Financial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-05T14:54:48.742Z. | |
px.change | Change on the day | -17.95% | FMP | Financial Modeling Prep (FMP) · quote | |
px.change_abs | Change on the day, in dollars | −$0.0049 | FMP | Financial Modeling Prep (FMP) · quote | |
px.volume | Shares traded on the day | 9.9K | FMP | Financial Modeling Prep (FMP) · quote | |
fin.q_revenue | Revenue, Q4 FY2025 | $7M | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
fin.q_income | Net income, Q4 FY2025 | -$3M | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
fin.q_table | Quarterly income statement | 4 quarters through Q4 FY2025 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly), as filed | |
own.insiders | Insider transactions via FMP | 7 transactions · 3 purchases, 0 sales, 4 other transactions · 2 identified insiders · most recent available transactions | FMP | Financial Modeling Prep (FMP), carrying Form 4 transaction records — Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent. |
UNRECORDED — 8 facts from stored observations whose source was not recorded
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.range52 | 52-week range | $0.0101 – $0.30 | UNRECORDED | Stored company-profile observation — Captured 2026-10-04 | |
id.employees | Employees | 123 | UNRECORDED | Stored company-profile observation — Captured 2026-10-04 | |
id.ceo | Chief executive | Alfred Lim | UNRECORDED | Stored company-profile observation — Captured 2026-10-04 | |
fin.scores | Distress and quality screens | Piotroski F 2 | UNRECORDED | Stored financial-scores observation — Captured 2026-09-29 · Expired observation | |
fin.ratios | Return and yield ratios (trailing twelve months) | ROE 102.1% · current ratio 0.18 · earnings yield -13.0% · free-cash-flow yield -11.7% | UNRECORDED | Stored key metrics — Captured 2026-10-04 | |
earn.estimates | Analyst estimates, next fiscal year | FY2026 revenue $27.23M · EPS 0.00 · 1 analysts | UNRECORDED | Stored analyst estimates — Captured 2026-06-16 · Expired observation | |
earn.est_revenue | Revenue estimate, FY2026 | $27.23M | UNRECORDED | Stored analyst estimates — Captured 2026-06-16 · Expired observation | |
earn.est_eps | EPS estimate, FY2026 | $0.00 | UNRECORDED | Stored analyst estimates — Captured 2026-06-16 · Expired observation |
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Data provided for informational purposes only.